Skip to content

Investigating the Curcumin effects on ICU admitted traumatic brain injury patients' outcome

Investigating the Curcumin effects on ICU admitted traumatic brain injury patients' outcome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151221025641N7
Enrollment
272
Registered
2023-04-30
Start date
2023-06-05
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury. Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: Curcumin capsule containing 500 mg of curcumin and 5 mg of piperine (manufactured by Sabinsa Company), 1 capsule every 24 hours orally. Intervention 2: Control grou

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
Anesthesiology, critical care and pain management research center
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: The age of the patient is between 18 and 85 years; The reason for admission to the intensive care unit is head trauma; The patient or his first degree relatives have signed the consent form knowingly and freely; Glasgow coma scale is 8 and above; Less than 48 hours have passed since the loss of consciousness secondary to traumatic brain injury; There is no prohibition to receive oral medications.

Exclusion criteria

Exclusion criteria: Pregnancy; Lactation; Not being hemodynamically and metabolically stable and needing to receive vasoactive drugs; History of any type of disease or autoimmune disorders; History of chemotherapy and radiotherapy in the past month; History of any liver failure; Active bleeding; History of known Curcumin allergy.

Design outcomes

Primary

MeasureTime frame
SOFA score. Timepoint: Days 0 and 7. Method of measurement: SOFA score (The Sequential Organ Failure Assessment Score) calculation.;Glasgow coma scale (GCS) score. Timepoint: Days 0 and 7. Method of measurement: Glasgow coma scale (GCS) score calculation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Kianpour

Tehran University of Medical Sciences

parisa_kianpour@yahoo.com+98 21 6312 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026